Analysts and Calls -- Lehman Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Analysts and Calls -- Lehman

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who started this subject	10/8/2002 7:58:56 AM
From: Doc Bones	of 30

07:08 ET Lehman upgrades drug sector Lehman upgrades their sector rating for the major U.S. large cap pharmaceutical group to Positive from Negative based on the following premises: 1) increased visibility on 2003 earnings performance, 2) an upward inflection in forward earnings momentum for the drug group, 3) a potential for positive news flow on new drug approvals and filings in Q4, and 4) a valuation trough as measured by net present value/enterprise value analysis. [briefing.com] 10-08-02

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next